FINWIRES · TerminalLIVE
FINWIRES

イスラエル・レバノン停戦延長を受け、米国株式先物は取引開始前に上昇した。

-- 金曜の取引開始前、イスラエルとレバノンがホワイトハウスでの会談で停戦を3週間延長したことを受け、米株式先物は上昇した。 ダウ工業株30種平均先物は0.1%高、S&P500先物は0.5%高、ナスダック先物は1.4%安となった。 イスラエルとイランの支援を受けるレバノンの武装組織ヒズボラとの戦闘は、中東和平交渉における主要な議題となっている。ホルムズ海峡は事実上船舶の航行が禁止されたままであり、米国はイランの港湾封鎖を維持している。 トランプ大統領は、イランとの和平合意を急ぐつもりはないと述べ、「永続的な」和平を望んでいると語った。トランプ大統領はイラン政府を「分裂状態」と呼び、米イラン停戦を延長したが、イランの最高指導者モジタバ・ハメネイ師は木曜日、トランプ氏のイラン指導部内の分裂に関する主張を否定した。 トレーダーらは最新の決算発表に注目し、プロクター・アンド・ギャンブル(PG)は第3四半期の業績が好調だったと発表、HCAヘルスケア(HCA)は第1四半期の調整後利益と売上高が増加したと発表した。 原油価格は下落し、北海ブレント原油の期近先物は0.5%安の1バレル104.57ドル、米国産WTI原油は1.2%安の1バレル94.66ドルとなった。 ブルームバーグの推計によると、ミシガン大学が発表する4月の消費者信頼感指数最終値は、東部時間午前10時に発表予定で、速報値の47.6に対し、48.5となる見込みだ。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB